The tumor microbiome as a predictor of outcomes in patients with metastatic melanoma treated with immune checkpoint inhibitors
C. E. Wheeler, , S. S. Coleman, R. Hoyd, L. Denko, C. H. F. Chan, M. L. Churchman, N. Denko, R. D. Dodd, I. Eljilany, S. Hardikar, M. Husain, A. P. Ikeguchi, N. Jin, Q. Ma, M. D. McCarter, , A. C. Tan
This study identifies microbes associated with immunotherapy response in metastatic melanoma and shows that combining microbe abundances with gene expression improves survival prediction.
bioRxiv · May 24, 2023 · PreprintImmunology